![Anne-Catrin Uhlemann, MD, PhD Profile Headshot](https://www.vagelos.columbia.edu/sites/default/files/styles/cola_media_200/public/cups-profile/headshot/2bdf5880-f171-11ee-aaac-1d8497823fa1.jpg?itok=nbktlRIY 200w, https://www.vagelos.columbia.edu/sites/default/files/styles/cola_media_260/public/cups-profile/headshot/2bdf5880-f171-11ee-aaac-1d8497823fa1.jpg?itok=JwQF8D39 260w, https://www.vagelos.columbia.edu/sites/default/files/styles/cola_media_320/public/cups-profile/headshot/2bdf5880-f171-11ee-aaac-1d8497823fa1.jpg?itok=XyPq6PwF 320w, https://www.vagelos.columbia.edu/sites/default/files/styles/cola_media_400/public/cups-profile/headshot/2bdf5880-f171-11ee-aaac-1d8497823fa1.jpg?itok=7hinmNfF 400w, https://www.vagelos.columbia.edu/sites/default/files/styles/cola_media_520/public/cups-profile/headshot/2bdf5880-f171-11ee-aaac-1d8497823fa1.jpg?itok=ES_NwRAo 520w, https://www.vagelos.columbia.edu/sites/default/files/styles/cola_media_640/public/cups-profile/headshot/2bdf5880-f171-11ee-aaac-1d8497823fa1.jpg?itok=e2Ywzr-m 640w, https://www.vagelos.columbia.edu/sites/default/files/styles/cola_media_800/public/cups-profile/headshot/2bdf5880-f171-11ee-aaac-1d8497823fa1.jpg?itok=PGNjnGJZ 800w)
Overview
Dr. Anne-Catrin Uhlemann is the Florence Irving Assistant Professor of Medicine in the Division of Infectious Diseases in the College of Physicians and Surgeons at Columbia University.
Areas of Expertise / Conditions Treated
- Bacterial Infection
- Organ Transplant Infections
- Staphylococcal Infection
Academic Appointments
- Associate Professor of Medicine
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
- NewYork-Presbyterian Allen Hospital
Gender
- Female
Schedule an Appointment
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- HMO
- POS
- PPO
- Student Health
Affinity Health Plan
- Essential Plan
- Medicaid Managed Care
AgeWell
- Medicare Managed Care
- Special Needs
Amida Care
- Special Needs
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross/Blue Shield
- EPO
- HMO
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Quality Health Management
- Quality Health Management
RiverSpring
- Special Needs
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
WellCare
- Medicaid Managed Care
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- Eberhard-Karls University (Germany)
- Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
Committees, Societies, Councils
Member, American Society of Microbiology
Member, Infectious Diseases Society of America
Board Certifications
- Internal Medicine
- Infectious Disease
Honors & Awards
2014 - 2017 Florence Irving Assistant Professor of Medicine
2010 - 2013 Paul A. Marks Scholar, Columbia University
Research
Dr. Anne-Catrin Uhlemann is Associate Professor of Medicine in the Department of Medicine, Division of Infectious Diseases at Columbia University Irving Medical Center (CUIMC) in New York City, where she also directs the Microbiome & Pathogen Genomics Core. She received her MD from the University of Tubingen, Germany, and PhD in Molecular Parasitology from the University of London, where she studied mechanisms of drug resistance in Plasmodium falciparum. She then completed her residency training in Internal Medicine and a fellowship in Infectious Diseases at CUIMC in 2010. Her research leverages genomic tools and seeks to elucidate the molecular mechanisms and evolutionary underpinnings of drug-resistant microorganisms, spanning Staphylococcus aureus and diverse carbapenem-resistant Enterobacteriaceae (CRE). This includes studies on how CRE establish colonization in the gut microbiome and progress to cause infections in immunocompromised hosts as well as investigations into mechanisms of resistance to last line antibiotics to combat CRE infections such as polymyxins and novel carbapenemase inhibitors. In addition to investigating the evolution of bacterial pathogens, Dr. Anne-Catrin Uhlemann's laboratory is also contributing to research efforts related to the SARS-CoV-2 pandemic.
Research Interests
- Bacterial evolution
- Multi-drug resistant infections
Selected Publications
- Austin ED, Sullivan SB, Whittier S, Lowy FD, Uhlemann AC. Peripheral Intravenous Catheter Placement Is an Underrecognized Source of Staphylococcus aureus Bloodstream Infection. Open Forum Infect Dis. 2016 Apr 6;3(2):ofw072. eCollection 2016 Mar.
- Gomez-Simmonds A, Hu Y, Sullivan SB, Wang Z, Whittier S, Uhlemann AC. Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007 - 2014. J Antimicrob Chemother 2016; 71(8):2351-3.
- Pereira MR, Uhlemann AC. The evolving threat of carbapenem-resistant infections after liver transplantation: The case of Acinetobacter baumannii. Liver Transpl. 2016 May;22(5):579-81.
- Gomez-Simmonds A, Greenman M, Sullivan SB, Tanner JP, Sowash MG, Whittier S, Uhlemann AC. Population structure of Klebsiella pneumoniae causing bloodstream infections at a New York City tertiary care hospital: diversification of multidrug-resistant isolates. J Clin Microbiol 2015 Jul;53(7):2060-7.
- Uhlemann AC, Dordel J, Knox JR, Raven K, Parkhill J, Holden MT, Peacock SJ, Lowy FD. Molecular tracing of the emergence, diversification and transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci U S A 2014; 111(18):6738-43.
- Sowash MG, Uhlemann AC. Community-associated methicillin-resistant Staphylococcus aureus case studies. Methods Mol Biol. 2014;1085:25-69. Review.
- Uhlemann AC, Hafer C, Miko BA, Sowash MG, Sullivan SB, Shu Q, Lowy FD. Emergence of sequence type 398 as a community- and healthcare-associated methicillin-susceptible Staphylococcus aureus in Northern Manhattan. Clin Infect Dis 2013; 57:700-3.
- Uhlemann AC, Porcella SF, Trivedi S, Sullivan SB, Hafer C, Kennedy AD, Barbian KD, McCarthy AJ, Street C, Hirschberg DL, Lipkin WI, Lindsay JA, DeLeo FR, Lowy FD. Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. mBio 2012; 3: e00027-12.
- Uhlemann AC, Kennedy AD, Martens C, Porcella SF, Deleo FR, Lowy FD. Toward an understanding of the evolution of Staphylococcus aureus strain USA300 during colonization in community households. Genome Biol Evol 2012; 4:1275-85.
- Hafer C, Lin Y, Kornblum J, Lowy FD, Uhlemann AC. Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2012; 56:5845-51.
- Uhlemann AC, Fidock DA. Loss of malarial susceptibility to artemisinin in Thailand. Lancet 2012 379(9830):1928-30.
For a complete list of publications, please visit PubMed.gov